Biosyn is a specialty pharmaceutical company focused on the development and commercialization of novel drugs in the areas of infectious disease and reproductive health. Biosyn's product portfolio offers significant competitive advantages in areas where there is a critical need for new or alternative therapies. The company is developing product candidates for several key market segments including: 1) contraception and sexually transmitted diseases (STDs) 2) oral infections associated with immune-suppression and 3) skin and soft tissue infections (SSTIs) including acne and impetigo.